about
DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological FindingsBrain Structural Effects of Antidepressant Treatment in Major DepressionCerebral atrophy and white matter disruption in chronic schizophrenia.Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics studyIncreased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia.[Searching for psychosocial endophenotypes in schizophrenia: the innovative role of brain imaging].Classification of first-episode psychosis in a large cohort of patients using support vector machine and multiple kernel learning techniques.Normal pituitary volumes in chronic schizophrenia.Chronological age and its impact on associative learning proficiency and brain structure in middle adulthood.FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.Longitudinal investigation of the parietal lobe anatomy in bipolar disorder and its association with general functioning.Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study.Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.Hippocampal Subfield Volumes in Patients With First-Episode PsychosisAn Idiosyncratic, Acute, Systemic, and Life-Threatening Adverse Reaction in a Young Patient Treated With Clozapine: A Case ReportMRI features of clinical outcome in bipolar disorder: A selected review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translLate-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report
P50
Q26765967-6A7BC107-D424-44BE-B3A2-1963DB5523FFQ26786239-6B40BC35-83D0-4DF7-BE08-863C4AC353E6Q31059838-5BE0DD86-24D7-4941-9660-1902D433A3D7Q33848271-1B295271-12B0-477A-B902-8C5AFC265A93Q33990603-8C4707E8-7165-4C32-87B1-F131CAECFBB4Q34279316-6B4A4354-0B27-4719-99D2-0D9252B57693Q40185095-CE093EA2-6F8B-4487-B561-33E7FDE40BAFQ40258016-175C3057-C157-40C5-A175-9264412ACDABQ40437005-3F4534B1-D548-4E17-B9FC-36EB247F8C3CQ43288701-02AE0ED1-4C16-4526-8EDF-D5E4E256B2BBQ47663470-AC473C7F-3325-4A9C-8CC3-19A7A7A9390AQ47939266-C67F8BB1-7A9A-4B89-A6B7-06104049FD4EQ53798171-DF3E7F1D-050A-4182-9651-B75908EE9301Q56387216-FBAB9E54-A9D3-4CDB-A557-85B436B86DBDQ89101531-C9AC05E4-6BF5-4664-9FD5-2B43C2BD45E3Q89118746-9D2527AD-0537-4256-A31A-07F4DB06142BQ91036054-46D18F1D-74D3-4A30-B268-CD7A647FD948
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nicola Dusi
@en
Nicola Dusi
@nl
type
label
Nicola Dusi
@en
Nicola Dusi
@nl
prefLabel
Nicola Dusi
@en
Nicola Dusi
@nl
P31
P496
0000-0003-2204-0030